Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Interleukins × Clear all

NCT00283829 2007-11-29

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms